Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBBP8 pseudogene 1 (RBBP8P1) is classified as a pseudogene and is not protein-coding. While it shares sequence similarity with the functional RBBP8 gene, it does not produce an active protein and does not function as an enzyme, receptor, transporter, or other classical therapeutic target. Pseudogenes like RBBP8P1 are typically remnants of gene duplications or retrotranspositions and may have regulatory or genomic roles in some contexts, but no evidence supports RBBP8P1 as a therapeutic target or disease-associated biomarker at present. For information about therapeutic relevance, refer to the functional gene RBBP8, which is involved in DNA double-strand break repair and has implications in cancer biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RBBP8 pseudogene 1 (RBBP8P1).